Skip to main content
Clinical Trials/ACTRN12622000619741
ACTRN12622000619741
Recruiting
未知

The efficacy of adipose-derived stem cells as treatment of hypertrophic scar: a non-randomized controlled trial

Theddeus O. H. Prasetyono0 sites21 target enrollmentApril 26, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypertrophic scar
Sponsor
Theddeus O. H. Prasetyono
Enrollment
21
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 26, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Theddeus O. H. Prasetyono

Eligibility Criteria

Inclusion Criteria

  • The subject has a hypertrophic scar which has persisted for at least 3 months after the initial wound healed
  • \- The hypertrophic scar is of an area of at least 1 x 1 cm2
  • \- The hypertrophic scar is at least 5\-15 mm in thickness, confirmed with ultrasonography

Exclusion Criteria

  • \- The scar is diagnosed as keloid
  • \- The subject has systemic conditions such as diabetes mellitus, hypertension, etc
  • \- The subject smoked or consumed alcohol within the last 6 months
  • \- The hypertrophic scar received corticosteroid injection therapy within the last month
  • \- Subjects have allergies to penicillin, streptomycin, and amphotericin

Outcomes

Primary Outcomes

Not specified

Similar Trials